Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC in Duchenne Muscular Dystrophy
NCT06579352Phase 2Active, not recruiting
- Sponsor
- MED Institute
- Start
- Aug 2024
- Primary completion
- Oct 2028
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in Duchenne muscular dystrophy (DMD), sponsored by MED Institute. Started Aug 2024; status: active, not recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT06579352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06579352.